Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome

Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome

We here report on a 74-year-old man diagnosed with a pT3cN0 BRAF-mutated and mismatch repair-deficient adenocarcinoma in the colon ascendens and 3 liver metastases. After hemicolectomy, the patient received treatment with the PD-1 inhibitor pembrolizumab. Three weeks later (on day 22), laboratory te...

Full description

Bibliographic Details
Main Authors: Daniel Giglio, Henrik Berntsson, Åsa Fred, Lars Ny
Format: Article
Language:English
Published: Karger Publishers 2020-10-01
Series:Case Reports in Oncology
Subjects:
colorectal adenocarcinoma
hepatocellular carcinoma
microsatellite-instable tumor
pembrolizumab
myositis
myasthenia gravis
Online Access:https://www.karger.com/Article/FullText/510740

Internet

https://www.karger.com/Article/FullText/510740

Similar Items